Powered By
| The Micronase brand name has been discontinued in the U.S. for reasons unrelated to safety or effectiveness. Other brand names or generic alternatives may be available. If you’re currently taking this medication, talk to your healthcare provider about safe options for transitioning to a different treatment. |
Overview
Micronase was a prescription drug approved by the U.S. Food and Drug Administration (FDA) to help improve blood glucose control in adults with type 2 diabetes. Micronase was considered an adjunct treatment to diet and exercise. Micronase was also referred to by its drug name, glyburide.
Micronase was a sulfonylurea. Micronase was believed to work by increasing the amount of insulin released by the pancreas.
How was it taken?
Prescribing information stated that Micronase was generally taken once daily, in the morning with breakfast. Micronase came in tablet form.
Side effects
The FDA-approved label for Micronase listed common side effects including hypoglycemia (low blood sugar), nausea, heartburn, full-stomach sensation, joint or muscle pain, blurry vision, pale skin, bleeding easily, rash, and itching.
Rare but serious side effects listed for Micronase included jaundice and systemic allergic reaction.
For more information about this treatment, visit:
More resources from DiabetesTeam that mention Micronase
Become a member to get even more
Join
